Axogen Cash Flow Statement
NASDAQ: AXGNHealthcareMedical DevicesUSD
36.13-0.05 (-0.14%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Axogen free cash flow
In fiscal 2025, Axogen generated $812,000 of operating cash flow and spent $3.7 million on capital expenditures. That left free cash flow of -$2.9 million, a free-cash-flow margin of -1.3% of revenue. Free cash flow was down 304.5% from the prior year's $1.4 million.
Summary generated from market data by MetaCap's automated system. Methodology
Axogen cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -15.70M | -9.96M | -21.72M | -28.95M | -26.98M | -23.79M | -29.14M | -22.40M | -10.45M | -14.41M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 6.66M | 6.47M | 4.22M | 2.83M | 2.74M | 1.53M | 933.00K | 774.00K | 488.00K | 362.00K |
| Stock-Based Compensation | 30.11M | 15.91M | 14.42M | 15.59M | 10.92M | 8.47M | 10.30M | 7.61M | 3.61M | 1.39M |
| Change in Working Capital | -22.67M | -8.01M | -1.19M | -5.95M | -5.82M | 877.00K | -3.67M | -7.66M | -4.88M | -2.32M |
| Operating Cash Flow | 812.00K | 4.54M | -5.72M | -16.07M | -13.40M | -9.63M | -19.87M | -17.86M | -9.24M | -11.24M |
| Capital Expenditures | -3.75M | -3.10M | -13.87M | -20.08M | -27.81M | -21.91M | -4.66M | -6.28M | -1.10M | -931.00K |
| Investing Cash Flow | -5.32M | -10.30M | 19.25M | -3.20M | -23.65M | -16.96M | 27.27M | -98.19M | -1.29M | -1.16M |
| Debt Issued | — | — | 0 | 0 | 15.00M | 35.00M | 0 | 0 | — | — |
| Debt Repaid | — | — | — | 0 | 0 | 0 | 0 | -22.51M | -21.00K | -2.45M |
| Financing Cash Flow | 10.50M | 2.29M | 1.95M | 1.79M | 20.45M | 40.47M | 4.03M | 109.84M | 17.02M | 16.50M |
| Net Change in Cash | 5.99M | -3.47M | 15.49M | -17.47M | -16.60M | 13.88M | 11.43M | -6.21M | 6.49M | 4.11M |
| Free Cash Flow | -2.93M | 1.43M | -19.59M | -36.14M | -41.22M | -31.53M | -24.54M | -24.14M | -10.34M | -12.17M |
This table shows 10 annual periods of Axogen's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow AXGN's reporting calendar. What is a cash flow statement?